ESMO Asia 2022 | Improving outcomes for patients with head and neck cancer

Avinash Khadela, PhD, L.M. College Of Pharmacy, Ahmedabad, India, discusses the key unmet needs for patients with head and neck cancer, focusing on the importance of personalized therapy. The development of novel clinical biomarkers and drugs targeting these biomarkers has the potential to greatly improve personalised therapy for these patients, which should subsequently improve outcomes. Dr Khadela also discusses the importance of collecting real-world data on immunotherapies, as well as the need to improve neoadjuvant and adjuvant therapy to prevent disease recurrence. This interview took place at the European Society for Medical Oncology (ESMO) Asia congress 2022 in Singapore.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.